Sonder Futures — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
HealthtechHouston, US
Shane Sevier(Executive Officer)Eduardo Fonseca(Executive Officer, Director)
BoardNeeraj Agrawal(Director)Vipul Patel(Director)
Board seatFrederic Moll· per SEC Form D · $39.7M raise · filed Aug 2025
Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prashant Chopra(Executive Officer, Director, Promoter)
BoardRony Abovitz(Co-founding Advisor)
Board seatFrederic Moll· per SEC Form D · $17.7M raise · filed Aug 2025
Co-investorsShangBay Capital LLCTSVCDolma Ventures
HealthtechSan Mateo, US
Matthew McLean(Executive Officer)Marcus Weber(Executive Officer, Director)Jayant Charthad(Executive Officer, Director)
BoardAndrew Weiss(Director)in
Board seatJay WatkinsAndy McGibbon· per SEC Form D · $17.6M raise · filed Dec 2025
Co-investorsSonder Capital
HealthtechBothell, US
Eric Siebel(Executive Officer)Juan Vegarra(Executive Officer)Luis Savastano(Executive Officer)David Goesling(Executive Officer)Russell Garrison(Executive Officer, Director)Gerald McMorrow(Executive Officer, Director)
Board seatFrederic Moll· per SEC Form D · $37.3M raise · filed Mar 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.